2025 News Feed
Pennington Biomedical Appoints Dr. Corby Martin as the Associate Executive Director for Scientific Education
LSU’s Pennington Biomedical Research Center announced that Dr. Corby Martin has been appointed as the Associate Executive Director for Scientific Education, effective November 1, 2025.
Learn More
Severity of Obesity Closely Associated with Likelihood of Disease Burden in US National Study
Obesity severity is incrementally associated with a broad range of cardiometabolic and renal disease burden, as discovered by researchers at Pennington Biomedical Research Center. Recently published in Obesity, the paper “Association of Obesity Severity with Cardiometabolic and Renal Disease Burden in the United States,” explored the relationship through a cross-sectional study of data from the U.S. Behavioral Risk Factor Surveillance System survey.
Learn More
Pennington Biomedical’s Dr. Leanne Redman Recruited to Lead the Charles Perkins Centre at the University of Sydney
Following an extensive worldwide search, Dr. Leanne Redman has been appointed Academic Director of the Charles Perkins Centre, the University of Sydney’s first and largest multidisciplinary research initiative. A Professor of Clinical Science, Dr. Redman currently holds a number of positions at LSU’s Pennington Biomedical Research Center including the LPFA Endowed Chair in Nutrition and Associate Executive Director for Scientific Education. Over the past twenty years, she has pioneered groundbreaking research on women’s health issues, including the study of obesity in pregnancy, the optimisation of maternal nutrition and childhood obesity prevention.
Learn More
Pennington Biomedical Encourages “Small Shifts” for a Healthier, More Energized Holiday Season
As the holiday season approaches, Pennington Biomedical Research Center is sharing tips and advice to help families enjoy their celebrations while feeling their best. Building on the Center’s popular “Small Shifts” campaign, the message this year is simple: even modest changes to how we approach food, movement, and mindfulness can make a big difference in our energy, health, and enjoyment.
Learn More
Four Pennington Biomedical Researchers Recognized among the World’s Most Highly Cited Researchers
Four researchers from LSU’s Pennington Biomedical Research Center have been named among the world’s most highly cited scientists, according to the 2025 Highly Cited Researchers list from Clarivate Analytics. Pennington Biomedical’s Dr. Steven Heymsfield, Dr. Peter Katzmarzyk, Dr. Eric Ravussin, and Dr. Donna Ryan are recognized among the top 1 percent of researchers whose work has demonstrated significant and broad influence in their respective fields. The list identifies scientists whose publications rank among the most cited globally over the past 11 years, as measured in the Web of Science database.
Learn More
Dr. Ann Coulter of Pennington Biomedical Presents New Approach to Fat Metabolism Activation Therapies at Bio on the Bayou Conference
Dr. Ann Coulter of Pennington Biomedical Research Center recently presented research on a novel nutritional supplement that targets fat cells to stimulate weight loss at the Bio on the Bayou conference in New Orleans.
Learn More
The Power of Discovery: GLP-1 Receptor Agonists
Life-changing medications don’t happen overnight. For years, Pennington Biomedical Research Center has been instrumental in GLP-1 drug research, ensuring that these treatments are not only effective but also safe for people across the globe. Today, GLP-1 drugs give millions of people new hope in their weight-loss journey, helping them achieve healthier lives and better long-term outcomes. But there’s still more to learn, and our scientists are already hard at work on the next generation of treatments.
Learn More
Louisiana Environmental influences on Child Health Outcomes, ECHO, Collaboration Secures Federal Funding Renewal
Louisiana’s Environmental Influences on Child Health Outcomes, or ECHO program, has secured a share of $13 million in funding from the National Institutes of Health, or NIH. The award, which is for the program’s third award cycle, will support its efforts and research for five years.
Learn More
Pennington Biomedical Researchers Head to Atlanta for ObesityWeek 2025
Pennington Biomedical researchers are preparing to head to Atlanta for ObesityWeek 2025, presented by The Obesity Society, or TOS. Taking place Nov. 4-7, ObesityWeek is the preeminent international conference for obesity researchers and clinicians, featuring the latest developments in evidence-based obesity science. Pennington Biomedical will be well represented at the conference, as faculty members are not just participating in but are among the 250 experts leading courses, presentations and speaker panels during the event.
Learn More
Pennington Biomedical Awarded Renewal of NIH-funded Center to Advance Metabolic Disease Research and Train Future Scientists
Following a competitive review process, the National Institutes of Health (NIH) funding for Pennington Biomedical’s Metabolic Basis of Disease Center of Biomedical Research Excellence (COBRE) was renewed for an additional five years. This Phase II renewal builds on the momentum achieved since the center’s establishment in 2020, enabling continued support for young scientists who are focused on the mechanisms through which nutrition and metabolism contribute to health.
Learn More
